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In situ hybridization 
The hippocampus appears to be involved in tonic regulation of the hypothalamo-pituitary-adrenocortical axis via interactions with 
corticotropin-reloasing hormone (CRH) and arginine vasopressin (AVP)-contalning net, rons of the hypothalamic paraventricular nucleus (PVN). 
To further investigate the anatomical basis of such interactions, lesions were made to forebrain fiber tracts in positkm to communicate inhibitory 
information from the hippocampus to the PVN, Total fimbria-fornix transections (TFF) and lateral fimbria-fornix lesions (LFF) both 
significantly increased CRH mRNA levels in the medial parvocellular PVN, as assayed by semi-quantitative in situ Itybridization histochemistry. 
Medial fimbria-fornix lesions or section of the medial corticohypothalamic tracts (MCHT) did not influence CRH mRNA levels, The LFF group 
showed increases in both AVP mRNA and ACTH secretion, whereas no other lesion was effective in this regard. The results suggest: (I) 
hippocampal effercnts confertng tonic inhibition of the FIPA axi;; probably originate in regions contributing to the lateral extent of the fornix, 
representing structures in the ventral subiculum and ventral extent of CAI; (2) projections from the hippocampus to the medial basal 
hypolhalamus (~'avelling in the MCHT) are unlikely to affect HPA functkm; (3) hippocampus may influence the PVN CRI4/AVP neuron at 
multiple levels, i .  that LFF and TFF lesions have difi',,rential effects on PVN AVP mRNA levels and ACTH secretion. 
INTRODUCTION 
The excitability of the hypothalamo-pituitary- 
adrenocortical (HPA) axis is primarily controlled by a 
discrete set of neurons localized to the medial parvo. 
cellular division of the hypothalamic paraventricular 
nucleus (PVN). Via synthesis and secretion of corti- 
cotropin-releasing hormone (CRH) and arginine vaso- 
pressin (AVP) this region is able to tightly regulate the 
release of ACTH by adenohypophysial corticotrophs, 
and subsequently tune the excitation of glucocorticoid 
release by the adrenal cortex t, The ability of this 
discrete set of neurons to affect ACTH release is 
susceptible to both short-term and long-term negative 
feedback by glucocorticoid hormones, the end-point of 
the HPA cascade 16. 
While the negative feedback effects of glucocorti- 
colds on the HPA axis are well documented, precisely 
how this information is communicated to the medial 
parvocellular PVN neurons responsible for HPA acti- 
vation is presently poorly understood. A local site of 
steroid negative feedback on the CRH neuron is sug- 
gested by studies demonstrating normalization of 
adrenalectomy.induced up-regulation of CRH and 
AVP peptide expression in medial parvocellular neu- 
rons following implants of solid steroid pellets into the 
region of the PVN ~,33 (presumably mediated via en- 
dogenous type-2 glucocorticoid receptors4t). On the 
Correspondence: J.P, Herman, Department of Anatomy and Neurobiology, University of Kentucky Medical School, Lexington, KY 40536-0084, 
USA. Fax: ( I ) (606) 258-5oA6. 
other  hand, recent data f rom our  laboratory indicates 
that deafferentat ion of the hypothalamic PVN induces 
both C R H  and AVP m R N A  expression in parvocellu- 
lar PVN neurons in the face of  normal steroid levels 15, 
suggesting an important interplay between ne.ural cir- 
cuits and A C T H  secretagogue production at the level 
of  the PVN. Thus, it is likely that  both direct steroid 
feedback and indirect input via neural circuits are 
involved in regulation of PVN C R H / A V P  neurons. 
One  of  the primary candidate brain structures impli- 
cated in H P A  regulation is the hippocampal formation. 
This structure has been repeatedly shown to exhibit 
both a tonic inhibitory influence on HPA tone and to 
con t r ibu te  to cessat ion o f  an init iated stress 
response 9''0''3'19'2''3L46. In addition, studies focusing on 
type-I  and type-2 glucocorticoid receptor binding and 
m R N A  expression clearly demonstrate  that the hip- 
pocampus  possesses the highest levels of  both receptor  
subtypes in ['rain, rendering this structure a likely 
target  for integration of  blood-borne glucocorticoid 
signals into a physiological r e sponse  2'H'27,2s'32'3~'42. 
The tonic inhibitory effect of  the hippocampus on 
the H P A  axis is likely to be integrated at the level of  
the PVN. We have previously demonstrated that both 
C R H  and AVP mRNAs  are markedly increased in the 
medial parvocellular PVN ir~ response to hippocampal  
extirpation, implicating the hippocampal formation in 
tonic regulation of A C T H  secretagogue gene expres- 
sion I'~. A hippocampal effect on A C T H  secretagogue 
release was shown at the level of  secretion by Sapolsky 
and colleagues, who demonstra ted  an effect of  fim- 
br ia- fornix  section on hypophysial portal CRH,  AVP 
and oxytocin levels under  both basal and stressed con- 
ditions 3°. Electrophysiological evidence further sug- 
gests an inhibitory interaction between the hippocam- 
pus and PVN cells identified as projecting to the 
median eminence, likely to reflect CRH.producing 
cells 29. What  is not clear is how the hippocampus 
interacts with the PVN at an anatomical level. It is 
generally agreed that there is no direct connection 
between the hippocampus and the medial parvocellular 
PVN 34,39. However, potential  circuits can be delineated 
which interconnect the hippocampus with PVN via one 
intervening synapse. One such circuit involves hip- 
pocampal  connections with the lateral septum, bed 
nucleus of  the stria terrninalis and anterior hypothala- 
mic structures via the f imbr ia- formix system 2n'3s, These 
structures have been shown to project in turn to the 
medial parvocellular PVN 34 or to the region immedi- 
ately adjacent to the PVN 3'23'34. A second potential  
circuit involves h ippocampal-hypothalamic  connec- 
tions utilizing the medial corticohypothalamic tract, 
projecting from the anteroventral  subiculum to the 
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shell of  the ventromedial  nucleus, the arcuate nucleus, 
and the suprachiasmatic nucleus of  the hypothala- 
mus  2°'37. In the present report,  we at tempt  to function- 
ally and anatomically identify the critical circuit for 
tonic hippocampal  regulation of the H P A  axis via se- 
lective lesion of  forebrain fiber tract systems intercon- 
necting the hippocampus and PVN. 
MATERIALS AND METHODS 
Subjects and experimental protocols 
Subjects were male Sprague-Dawley rats, weighing 250-300 g at 
the time of surgery. All animals were housed on a 12:12 h light:dark 
cycle (lights on 06.00 h) in humidity- and temperature-controlled 
quarters. 
Bilateral lesions of the fimbria-fornix were made using a mi- 
croknife fashioned from the styler of a 16 gauge spinal needle. The 
stylet was sharpened along the bottom and either side (resembling a 
chisel) to render it appropriate for smooth penetration into the brain 
and for mediolateral passage through fimbria-fornix fibers. The 
animals were placed in a stereotaxic apparatus (flat skull position) 
and the knife was lowered to the following coordinates, derived from 
the stereotaxic atlas of Paxinos and Watson2S: AP - 1.3 mm relative 
to bregma, DV -5.0 mm and ML + 0.5 ram, and moved hack and 
forth several times along the mediolateral plane some 2.5 mm using 
the stereotaxie micrometer control. The knife was then retracted and 
re-inserted in the other side of the brain and the identical process 
repeated. Control rats had the knife lowered only 2 mm on either 
side of midline, without mediolateral passage. Representations of the 
extent of fimbria-formix lesions are shown in Figs. 1 and 3. 
For lesions of the medial corticohypothalamic tract (MCHT), 
knives were fashioned from ~ 23 gauge spinal needle. The stylet was 
threaded through the outer cannula, sharpened along the bottom 
and along two sides, and bent twice along an acute angle such that 
the knife shaft was parallel to the spinal needle cannula yet dis- 
placed by approximately 0,75 mm (see Fig. 2). The tip of the knife 
was positioned over Bregma, oriented anteriorly and dropped to the 
following coordinates: AP -0.4, DV -8.0, ML 0.0. Upon place- 
ment, the knife was then rotated 900 in either direction. The knife 
cut was designed to completely isolate the FVN from the MCHT, 
while sparing the post-commissural fornix passing nearby (see Figs. 2 
and 3), Control rats had the knife lowered without rotation. 
7~'ssue harlot, sting and treatment 
Animals were killed by rapid decapitation 10 days following 
experimental or control lesions. All kills took place between 09,00 
and 11.00 h. corresponding to 3-5 h after lights-on. Brains were 
rapidly removed and frozen in isopentane cooled to -45-50°C on 
dry ice. Blood was collected into heparinized tubes, spun at 1,500 
× g for 10 rain, and plasma frozen at - 70°C. for later analysis of 
ACTH and corticosterone. 
Brains were cryostat-sectloned at 15/~m and thaw-mounted onto 
polylysine-coated slides, All sections were stored at -70°C. until 
processing for in situ hybridization. 
In situ hybridization 
In situ hybridization was performed on sections sampled at 
regular (75-90/.tin) intervals through the PVN region according to a 
previously published protocol, with some minor modifications. Sec- 
tions were removed from the -70°C freezer, fixed in 4% 
paraformaldehyde for 30 rain and deproteinated with 0.2 ~g/ml 
proteinase K (i.5 mht at 37°C). After deproteination slides were 
washed for 1 rain in distilled H20, 1 rain in 0.1 M trieth~nolamine, 
and 10 rain in 0.1 M triethanolamine containing 0.25% acetic anhy- 
dride. Sections we~'~ then rinsed in distilled H20 and dehydrated 
through graded alcohols. 
Antisense 35S-labeled cRNA probes to proAVP (Pst l fragment, 
subcloned in pGEM3, courtesy T.G. Sherman) and proCRH (BamHI 
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fragment, subcloned in pGEM4, R.Thompson) eDNA clones were 
produced using standard in vitro transcription methodology. Plas- 
raids containing subcloned cDNAs were linearized with appropriate 
restriction enzymes to yield probes of desired length and C-G 
composition. The labeling reaction mixture contained 1 ~g linearized 
plasmid, 1 × SP6 transcription buffer (BRL), 125 p.Ci [3SS]UTP, 150 
/~M NTPs-UTP, 12.5 mM dithiothreitol, 20 U RNAsin and 6 U SP6 
(AVP) or T7 (CRH) polymerase. Reactions were incubated for 90 
rain at 3"PC, and labeled probe separated from free nucleotide over 
a Sephadex G50-50 column. The proAVP probe was a 225 bp cRNA 
coding for the C-terminal region of the proAVP molecule, which 
bears no significant homology with proOxytoein. The proCRH probe 
was a 770 bp cRNA derived from a rat CRH eDNA clone, including 
the peptide coding region (exon 2) of the rat CRH gene. 3sS-Labeled 
was added to the transcription reaction in amounts calculated to 
yield specific activities estimated at 5.63 x 104 Ci/mmol probe and 
1.73× 10 s Ci/mmol probe for proAVP and proCRH, respectively. 
Probe was diluted in hybridization buffer (75% formamide, 10% 
dextran sulfate, 3 x SSC, 50 mM sodium phosphate buffer, pH 7.4, 
l ×  Denhardt's. 0.1 mg/ml yeast tRNA and 0.1 mg/ml sheared 
salmon sperm DNA) to yield 1,000,000 dpm/30/~l buffer. 30 ~l of 
the probe solution was applied to each slide, the slides coverslipped, 
and coverslips sealed with rubber cement. Slides were incubated in 
sealed plastic boxes containing moistened loam at 55°C overnight. 
Following incubation, the coverslips were removed, the slides rinsed 
in 2× SSC and immersed in fresh 2× SSC for 20 rain. The tissue 
was then incubated with RNAse A (200 p,g/ml) at 37°C for 30 rain 
to degrade any remaining single-stranded RNA. Sections were then 
washed successively in 2×,  1× and 0.2× SSC for 10 min each, 
followed by a 1 h wasl~ in 0.2 × SSC at the hybridization tempera- 
ture. Sections were then dehydrated through alcohols, exposed to 
Kodak XAR X-ray film overnight, and subsequently emulsion- 
dipped, along with slide-mourned 15 p,m brain-paste standards con- 
taining known amounts of 35S-labeled L-methionine, in Kodak NTB2 
nuclear emulsion. Emulsion-dipped sections and standards were 
exposed for 7-10 days (AVP) or 17-21 days (CRH); batch develop- 
ment was based on the signal strength and signal-to-noise ratio of 
test slides developed at regular intervals. Because of the large 
number of animals, tissue was processed in two (AVP) or three 
(CRH) runs, with all groups equally represented in each run. 
Relative quantitation of in situ hybridization autoradiographs was 
conducted utilizing the NIH Image software package. Standards 
were prepared as described previously 13 and sectioned at 15 /zm, 
with adjacent sections reserved either for emulsion dipping or count- 
ing. Radioactivity of each standard was determined by counting 
standard sections adjacent to those used in the image analytic 
procedure in a Beckman liquid scintillation counter. Standard curves 
were derived by selecting the curve of best fit relating the optical 
density of digitized images of the 3sS-labeled brain paste standards 
(exposed along with the experimental sections) with the amount of 
radioactivity per unit area of standard. Emulsion-dipped sections 
were then digitized and subjected to analysis of optical density over 
the areas of interest in the images, those being the medial parvocel- 
lular and immediately adjacent posterior magnocellular divisions of 
the PVN. The region of PVN selected for both AVP aad CRH 
analyses was the mid-portion of the medial parvocellular PVN, 
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B= PosteriorDorsal HPC 
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Fig. I. Fimbria-fornix transections, For analysis of lesions, the fimbria-fo, nix (left panel) was subdivided according to the parcellation scheme of 
Meibach and Siegel 21. into zones A-E, with A representing the most medial extent (c~-ntaining efferents from the septal pole of the 
hippocampus) and E the most lateral (containing efft,,c,ats from the temporal pole of the hippocampus). The distribution of efferents from 
various subfields of the hippocampal formation are depicted in their approximate locations (SUB, subiculum; CA[, cornu ammonis pyramidal 
cell layer 1; CA3, cornu ammonis pyramidal cell layer 3), Lesions are illustrated in the right panel, showing the most extensive (left) and least 
extensive (right} lesion included in the respective groups, LFF, lateral fimbria-fornix lesion; MFF, medial fimbria-fornix lesion; TFF, total 
fimbria-fornix lesion. The ]eft panel was a scanned and modified image from the atlas of Paxinos and Watson 2s, reproduced with permission. 
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corresponding to 1,600-1,900/~m posterior to bregma according to 
the coordinate scheme of Paxinos and Watson 25. Areas of interest 
were defined on cytoarchitectonic criteria from adjacent Nissl-stained 
sections and by patterns of grain localization. Scattered magnocellu- 
lar neurons in the medial parvocellular PVN interfere with accurate 
determination of the relative amount of parvocellular AVP mRNA 
localized in this region. We therefore endeavored to exclude magno- 
cellular AVP neurons from our analysis of the parvocellular PVN on 
the basis of: (1) size and relative grain density and (2) known 
localization from neighboring Nissl-stained sections. Integrated opti- 
cal density measures were then calculated by computing the product 
of the average optical density within the sample and the area 
sampled. All optical density measures utilized fell within the linear 
range of the computed standard curve. 
Hormone assays 
Plasma samples were extracted before assay with Sep-Pak C-18 
cartridges. ACTH was assayed by radioimmunoassay using a rabbit 
ACTH antibody directed against ACTH (11-24). Details of this 
assay have been described previously 4s, Plasma CORT was also 
determined by RIA, using a rabbit antibody directed against corti- 
costerone (conjugated with bovine serum albumin) (B3A, courtesy of 
M. Morano and E. Estivariz). This antiserum cross-reacts 2% with 
cortisol and deoxTcorticosterone and less than 0.3% with proges- 
terone, estradiol, testosterone, and aldosterone. Extracted and 
lyophilized samples were resuspended in 50 mM sodium phosphate 
buffer (pH 7.5) in the presence of 2.5% bovine serum albumin. The 
corticosterone antiserum was used at a final concentration of 1:4,000. 
[3H]Corticosterone (Amersham, Arlington Heights, IL) was used as 
a trace. Bound and free steroids were separated via centrilugation 
(3,000 x g) in the presence of a 1%/0.1% charcoai/dextran mix- 
ture. Corticosterone concentrations of 0.5 /Lg/dl were reliably de- 
tected using this assay system (intra-assay coefficient of variation = 
2%, inter-assay coefficient of variation = 3%). 
Data analysis 
All data were analyzed by one-way ANOVA, followed by Dun- 
can's Multiple Range post-hoc analysis to differentiate among indi- 
vidual means (SuperANOVA software, Abacus Concepts, Berkeley, 
CA). All ANOVAs used the mean integrated optical density, ACTH 
and CORT values obtained for each individual animal, and were 
grouped according to surgery (sham fimbria-fornix (SH-FF) and 
sham MCHT (SH-MCHT)) or histologically verified lesions (LFF, 
TFF, MFF, MCHT). Note that due to tissue availability, AVP 
analyses were only performed on 2 of 3 runs. 
RESULTS 
Representative lesions of the FF and MCHT are 
presented in Figs. 1-3. Note that the total FF (TFF), 
lateral FF (LFF) and medial FF (MFF) groups were 
defined post-hoe on the basis of the histological ap- 
pearance of the lesion sites in Nissl-stained sections. 
Criteria for successful lesions were as follows: LFF, 
destruction of the lateral extent of the fimbria-fornix 
(Fig. 1B, zones C-D, with subtotal damage of zone E; 
MCHT 
MCHT 18 _ J 
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Fig. 2. Medial corticohypothalamic tract (MCHT) transections. The MCHT was sectioned at approximately the level depicted in the left panel, 
with the knife blade positioned between the origin of the MCHT from the fornix and fascicles descending into the hypothalamus. The knife was 
designed to be interposed between the two descending columns of the fornix (see right panel) to obviate damage to information travelling in this 
fiber system, and was positioned to clearly avoid damage to the paraventricular nucleus (PVN). The right panel shows the largest (top) and most 
circumscribed (bottom) MCHT cuts utilized in our data analysis. Both panels are modified images from the atlas of Paxinos and Watson 25, 
reproduced with permission. 
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Fig. 3); MFF, destruction of  the medial region o f  the 
fimbria-fornix (Fig. 1B, zones  A - C ;  Fig. 3); TFF, 
destruction of  the majority o f  the fimbria-fornix (Fig 
IB, zones  A - D ,  with some sparing of  the lateral tip of  
the fornix (zone E) generally present; Fig, 3); and 
MCHT (Figs. 2 and 3), interposition of  the knife scar 
between the descending columns o f  the fornix and the 
third ventricle in such a manner  that descending fasci- 
cles o f  the MCHT were interrupted (Fig. 2) (with no 
accompanying damage to either the fornix or PVN).  
Note  that the TFF lesion resulted in more extensive 
damage to overlying cortex than the MFF or LFF 
groups (e.g. see Fig. 3). 
Analysis o f  CRH and A V P  m R N A  expression fol- 
lowing the respective lesions is presented in Figs. 4 -6 .  
Determinations were made on 2 - 4  {4 -8  PVN) sections 
through the mid-portion of  the PVN of  each animal 
(1,600-1,900 ~ m  posterior to bregma). As can be ap- 
preciated in Fig. 4, an up-regulation o f  CRH m R N A  
can be observed in the medial parvocellular PVN of  
rats receiving either TFF or LFF lesions. In contrast, 
no obvious changes were observed in the MFF and 
MCHT groups relative to sham-operated controls. 
Densitometric data reiterates the qualitative micro- 
scopic observations, demonstrating a significant effect 
of  treatment on CRH m R N A  levels (Fig. 5) (F~,4~ = 
3.74, P < 0.01) upon one-way A N O V A .  Post-hoe analy- 
sis using Duncan's  Multiple Range test revealed signif- 
icant differences between both the TFF and LFF 
groups and sham-operated controls ( P  < 0.05). 
Changes in AVP m R N A  can be seen as an increase 
in hybridization density over the medial parvocellular 
PVN following disruption of  the fimbria-fornix, allow- 
ing visualization in some sections o f  clear parvocellular 
AVP neurons (Fig. 6). Densitometric examination (Fig. 
5) revealed a significant change in medial parvoceIlular 
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Fig. 3. Histology of representative total fimbria-fornix (TFFXFF57) (A), lateral fimbria-fornix (LFF) (FF65) (B), medial fimbria-fornix (MFF) 
(FF44) (C) and medial corticohypothalamic tract (MCHT) (MCHTIS) (D) lesions, stained for Nissl substance with Cresyl violet. A: TFF lesions 
typical compromised the vast majority of the fimbria-fornix at the level depicted, with some sparing of the ventrolateral tip (see arrows). Cortical 
damage was sustained in the area overlying the knife cut (asterisks), B: LFF lesions were confined to the lateral region of the fimbria-fornix, 
corresponding roughly to zones C and D in Fig, I, The area of lesion is delimited by the arrows, Note that the damage to overlying cortex is more 
limited compared with that seen in TFF lesions, C: MFF lesions typically encompassed the medial half of the fimbria-fornix at this level 
(denoted by arrows); substantial sparing of zones C and D (Fig, I) are seen in these lesions, The extent of damage to overlying cortex (not fully 
appreciated in this section) was similar to that seen for LFF lesions, D: MCHT lesions involved bilateral interposition of a microknife blade 
between the fornix and the path of descending fibers of the MCHT, The knife sears are denoted by small arrows, and the mechanical damage 
caused by positioning of the knife is demonstrated by the larger arrows. The asterisks illustrate the approach taken to position the knife blade. 
Note that the knife scars are in a position appropriate to bilaterally bisect the MCHT (compare with Fig. 2), without causing significant damage 
to the nearby post-commissural fornix. Bar = 1 ram. 
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Fig. 4. Examples of CRH mRNA in the medial parvocellular division of the paraventricular nucleus of rats receiving sham lesions (A), medial 
fimbria-fornix transections (B), medial corticohypothalamic tract lesions (C), lateral fimbria-fornix transections (D), and total fimbria-fornix 
transections (E). These sections were selected to depict approximate percentage of control values at their respective rostrocaudal level of the 
nucleus (integrated OD value of A (SHAM) -- 121% of mean control (SHAM) values at this anatomical level, B (MFF) ffi 91%, C (MCHT) = 94%, 
D (LFF) = 198%, E (TFF) ffi 258%). Cells depicted in F and G represent qualitative differences in grain density/cell seen in TFF (F) vs. SHAM 
(G) animals. Bar = I00/~m. 
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Fig. 5. Semi-quantitative analysis of CRII and AVP mRNA expres- 
sion in the paraventricular nucleus following sham medial corticohy- 
pothalamic tract lesion (SH-MCHT), medial corticohypothalamic 
tract lesions (MCHT), sham fimbria-fornix lesion (SH-FF), total 
fimbria-fornix lesions (TFF). lateral fimbria-fornix lesions (LFF), or 
medial flmbria-fornix lesions (MFF). The MCHT lesion data and 
the TFF, LFF and MFF data are expressed as percentages of the 
SH-MCHT and SH-FF control groups, respectively; please note that 
these two control groups did not differ from one another, in re- 
sponse to TFF or LFF, CRH mRNA levels in the medial parvocellu- 
lar PVN are significantly increased over sham.operated controls 
(P < 0.05 for both lesions, Duncan's Multiple Range test, following 
significant one-way ANOVA). AVP mRNA levels were increased in 
the medial parvoeellular (rap) PVN of LFF rats (P < 0.05, Duncan's 
Multiple Range test, following significant one-way ANOVA). There 
was no effect of lesion on posterior magnocellular (pro) PVN AVP 
mRNA content. Numbers in parentheses indicate the number of 
animals/group for the CRH (first number) and AVP (second num- 
ber) analyses. 
PVN AVP mRNA levels (Fs., s = 2.62, P < 0.05); this 
effect was primarily carried by the LFF group, as only 
the LFF lesion was statistically different±able from 
sham-operated controls by post-hoe analysis ( P  < 0.05, 
Duncan's Multiple Range test). Magnocellular AVP 
mRNA levels were not altered by any surgical treat- 
ment. 
Radioimmunoassay of trunk blood samples from the 
respective groups are presented in Table I. There  was 
a significant effect of group on plasma ACTH by 
one-way ANOVA (F5.52 = 2.34, P = 0.05); upon post- 
hoc analysis, only the LFF group was different±able 
from control animals (Duncan's Multiple Range test 
( P <  0.05)). There was no significant effect of treat- 
ment on plasma corticosterone (CORT) levels (overall 
A'NOVA: Fs,s2--1.15, P =  0.35). 
DISCUSSION 
This study demonstrates that lesions of  the 
fimbria-fornix system can reliably elicit increases in 
basal CRH and AVP mRNA levels in medial parvocel- 
lular PVN neurons known to control HPA axis func- 
tion. Notably, this effect appears to be quite localized 
within the fornix system; lesions of  the lateral extent of  
the fornix (approximately corresponding to zones C 
and D of Me•bach and Siegel2°: see Fig. 1) were most 
efficacious in producing basal up-regulation of both 
CRH and AVP mRNA and increases in plasma ACTH 
levels, whereas medial lesions were unable to signifi- 
cantly up-regulate ACTH secretagogue mRNAs. These 
data support the hypothesis that information travelling 
in zones C and D of the fornix, emanating from CA1 
and ventral subicular pyramidal cells of the ventral 
hippoeampus, are likely to be the principle hippocam- 
pal regulators of  basal HPA tone. 
Lesions of the MCHT were unable to affect CRH 
and AVP mRNA production and HPA axis secretions. 
Interestingly, fibers of the MCH T typically travel in 
zones D and E of the fornix system, many of which 
should be spared by the LFF and TF F  lesions. Taken 
together, these data suggest that direct projections of  
hippocampal neurons to the region of the mediobasal 
hypothalamus are unlikely to be primary modulators of 
basal ACTH secretagogue production. 
The parcellation of h ippocampaI-HPA interactions 
to the lateral extent of the fornix system agrees with 
data obtained by Fischette et al. t°, who demonstrated a 
significant disruption of basal C O R T  secretion follow- 
ing lateral but not medial fimbria-fornix transeetions. 
In addition, ventral hippoeampal cortisol implants ap- 
pear to disrupt daily CORT secretions "~s, suggesting 
that the region giving rise to lateral fornical fibers may 
be implicated in steroid-mediated HPA control, Inter- 
estingly, both of the above effects were manifested as a 
disruption of circadian CORT rhythmicity, it is known 
TABLE i 
Plasma ACTH and corticosterane lecels following forebrain fiber tract 
lesion 
Slt-MCHT, sham-medial corticohypothalamic tractl MCHT, medial 
corticohypothalamic tract; SH-FF, sham fimbria-fornix; TFF, total 
fimbria-fornix; LFF, lateral fimbria-fornix; MFF, medial fimbria- 
fornix. 
Lesion group Plasma AC?H Plasma CORT 
( fmol / ml) 
SH-MCHT 24.0+ 4.9 (9) a 3.18+ 1.59 (10) 
M CHT 28.3 ± 13.5 ( i I) 1.65 + 0.94 (l I ) 
SH-FF 33.6± 6.0 (22) 3.41 + !.05 (20) 
TFF 57.2±14.4 (6) 3.00+0.66 (5) 
LFF 76.8+21.7 (5) h 5.07±2.83 (6) 
MFF 54.6+21.5 (5) 6.87±2.41 (6) 
a Mean±S.E.M. Numbers in parenthesis reflect the number of 
animals/groups. 
t, Significantly different from the SH-FF group by Duncan's Multiple 
Range Test, following signifcant one-way ANOVA. 
/ 
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Fig. 6. Examples of AVP mRNA distribution in the medial parvocellular division of the paraventricular nucleus of rats receiving sham lesion 
(A,B) or lateral fimbria-fornix transection (LFF) (C,D). Note the presence of positive hybridization in the medial parvocellular zone in the LFF 
animal (C), many of which can be localized to the small, lightly hybridized neuronal profiles seen in panel D (arrows), No such hybridization 
signal is seen in the parvocellular zone of SHAM animals (A), or in identifiable parvocellular elements (B). Asterisks depict the same neurons in 
panels A and B and panels C and D; these neurons are representative of scattered magnocellular neurons commonly seen in the medial 
parvocellular PVN. Bars ffi 100/~m (A,C) and 40/~m (B,D), 
that the HPA axis shows marked circadian rhythms at 
multiple levels, including CORT, ACTH and CRH 
secretion 6'aa'24'4" and CRH mRNA production !s'43. In 
combination with the present data, these studies sug- 
gest the possibility that information carried from the 
ventral hippocampus via the lateral fornix may be 
involved in steroid-mediated modulation of HPA 
rhythms. However, comparison of the previous circa- 
dian studies of CRH mRNA regulation with hippocam- 
pus-.fornix lesion results does yield some interesting 
discrepancies to keep in mind. First, the daily excur- 
sion of CRH mRNA content in the PVN is consider- 
ably less than changes observed following hippocam- 
pal-fornix lesions 1~'43. Second, under lesion conditions 
AVP mRNA is significantly increased in parvoceUular 
PVN neurons, whereas such changes are not evident 
across the circadian cycle (Herman, McEwen, Chao 
and Watson, unpublished observations). Such data 
seems to argue that the lesion condition is a more 
potent activator of the CRH/AVP neuron than circa- 
dian drive. While one could hypothesize that total 
removal of circadian inhibitory events may transcend 
those events occuring across the daily cyeTe, the possi- 
bility that ventral hippocampus damage/disconnection 
drives CRH/AVP mRNA expression in the parvocel. 
lular PVN without regard to time of day merits further 
attention as well. 
The plasma hormone data present an interesting 
pattern. In the LFF group, ACTH secretion appears to 
be increased without an accompanying change in 
CORT levels. One explanation for this phenomenon is 
that slight elevations of ACTH in the LFF group may 
reflect the beginnings of a stress response to the events 
associated with killing. Our animals are killed within 1 
rain of retrieval from their home cages; however, the 
commotion associated with vivarium room noise, re- 
moval of other rats from neighboring, etc, may be 
sufficient to initiate ACTH secretion in animals (e.g. 
LFF-damaged rats) whose HPA axis has been previ- 
ously sensitized to stress. Up-regulation of CRH and 
AVP mRNAs in LFF rats may then be the conse- 
quence of an increase in overall sensitivity of the axis 
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driven by hippocampal disconnection, and presct ibes a 
preparatory (i.e. encoding predispositions to synthesis/ 
secrete) rather than permissive (i.e. encoding tonic 
inhibition of biosynthesis/secretion) interaction of this 
structure with the HPA axis. 
Differential effects on the HPA axis were observed 
between groups with total fornix lesions and lesions 
confined to the lateral fornix. It appears that LFF 
lesion results in increased AVP mRNA, CRH mRNA 
and ACTH levels, while only CRH mRNA changes are 
seen upon TFF lesions. This pattern raises the possibil- 
ity that different classes of information relevant to 
HPA axis regulation are encoded in different regions 
of the hippocampus or different hippocampal sub- 
fields. There is precedent for such effects in the litera- 
ture, in that stimulation of CA1 appears excitatory to 
corticosteroid secretion in anesthetized preparations, 
whereas CA3 or dentate gyrus stimulation appears 
primarily inhibitory s. In addition, lesion of the dentate 
gyrus with intraventricular colchicine decreases rather 
than increases CRH mRNA in the PVN 4. By this logic, 
one would suspect that the inhibitory actions of ventral 
hippocampal structures on the PVN (seen in the LFF 
condition) may be tempered in TFF animals by re- 
moval of other classes of outflov, emanating from func- 
tionally distinct hippocampal regions. 
The presence of increased AVP mRNA and ele- 
vated ACTH in the LFF group may be connected, it is 
known that AVP and CRH act synergistically at the 
corticotroph to release ACTH t2, and that the extent of 
co-localization of AVP and CRH in neurosecrctory 
granules in the external lamina of the median emi- 
nence increases dramatically with stimulation (chronic 
stress or adrenalectomy) 44,4s. Interestingly, in both the 
case of TFF and LFF CRH mRNA was increased, yet 
ACTH secretion was only affccted under conditions 
where AVP mRNA was increased as well (LFF). These 
results raise the possibility that the ACTH change may 
be connected to increased AVP synthesis, with puta- 
tively increased levels of AVP at the median eminence 
capable of promoting greater corticotroph release of 
ACTH per stimulatory episode. This hypothesis re. 
mains to be definitively addressed, 
it should be noted that the TFF lesion resulted in 
more extensive cortical damage than either the LFF or 
MFF transections. However, the fact that the effects of 
LFF on several measures of HPA activity were as great 
as or greater than those of the TFF group precludes a 
role for differential cortical destruction in the present 
experiments. 
It is clear from this study that levels of CRH and 
AVP mRNAs are subject to regulation by hippocampal 
structures, it remains to be determined which sub-hip- 
pocampal structures are capable of directing hip- 
pocampal influeace to the PVN itself. Certainly, dorsal 
hippocampal projections travelling in fornix zones A 
and B (compromised by MFF lesions) are not likely to 
be important HPA-active elements. These efferents 
distribute in a topographic fashion to the dorsal and 
lateral septum 2°'3s'47. In fact, in general the septum is a 
poor candidate for a hippocampus-PVN relay, as an- 
terograde tracing data suggest that descending septal 
fibers largely avoid the PVN, skirting the outer bound- 
aries of the nucleus z3,~4. In addition, the temperoven- 
tral hippocampal projections to the mediobasal hy- 
pothalamus are ruled out by the ineffectiveness of the 
MCHT lesion to alter either CRH and AVP mRNA 
levels or HPA axis secretions. What remains is a rela- 
tively restricted source of potential interconnections 
between the ventral hippocampus-subiculum and se- 
lected structures in the tel- and di-encephalon. Previ- 
ous tract-tracing data strongly indicate that the best 
potential sources for such interaction lie in the bed 
nucleus of the stria terminalis, preoptic area, zona 
incerta and anterior hypothalamus. All of these regions 
receive afferents from the ventral subiculum, and in 
turn project to the medial parvocellular PVN 34.3s. in- 
deed, fibers projecting from hippocampus to these 
regions can be clearly localized to that region of the 
fornix (zone D) compromised by the LFF lesion s,2q). 
Subsequent functional-anatomical studies will be nec- 
essary to differentiate among these probable relay can- 
didates, 
While suggesting an involvement of ventral hip- 
pocampal corticosteroid receptors in regulation of PVN 
CRH/AVP mRNA expression, the present experi- 
ments do not directly address which receptor type, if 
any, is involved in these processes. However, consider- 
ation of literature reports and recent experiments per- 
formed in several laboratories would seem to point to 
the typed receptor as a potential vehicle for ventral 
hippocampal regulation of the HPA axis. Slusher's 
early study utilizing crystalline cortisol implants cer- 
tainly suggests a steroid.mediated ventral hippocampal 
influence on circadian CORT rhythmicity, although it 
does not implicate either receptor convincingly 3s. On 
the other hand, Ratka et al. describe an increase in 
AM CORT levels following intracerebroventricular in- 
jection of the type-I antagonist RU28318, leading to 
their ascribing a role for this receptor in circadian 
HPA cycles 26. Unfortunately, the locus of action of the 
RU28318 in this study is impossible to determine. 
Similarly, Dallman and colleagues, based on the rank- 
order potency of CORT, dexamethasone and aldos- 
terone on inhibition of adrenalectomy-induced ACTH 
up-regulation, attribute regulation of circadian ACTH 
secretion to (presumably extrahypothalamic) type-1 re- 
ceptors 7. Our efforts to assess type-1 inhibition of the 
C R H / A V P  parvocellular neurons indicate that 
chronic, systemic blockade of the typed corticosteroid 
receptor is able to reliably increase both CRH and 
AVP mRNA content in the morning, without affecting 
evening levels t4. Although derived from systemic ad- 
ministration, the fact that RU28318 treatment elicits 
effects similar in scope and magnitude to LFF lesions 
in animals killed at corresponding points in the day is 
suggestive of a circadian interaction between the type-1 
receptor and ventral hippocampus in regulation of the 
C RH/AVP neuron. 
The present studies provide evidence for specific, 
tonic inhibitory interactions between the ventral hip- 
pocampus-subiculum and PVN cells responsible for 
HPA activation, occurring via intervening structures in 
the ventral forebrain-hypothalamus. These studies lo- 
calize the effects seen following whole hippocampal 
removal t3 to this specific sub-region of the hippocam- 
pus, and point to a contribution of the ventral hip- 
pocampus in regulation of basal HPA tone. Subse- 
quent studies are necessary to determine whether the 
ventral hippocampal influence on medial parvocellular 
PVN neurons is related to circadian mechanisms 
and/or steroid receptors. 
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